Blueshift Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,155
Closed -$303K 500
2023
Q1
$303K Buy
+8,155
New +$303K 0.13% 218
2022
Q4
Sell
-3,718
Closed -$260K 705
2022
Q3
$260K Buy
+3,718
New +$260K 0.06% 442
2021
Q1
Sell
-1,745
Closed -$383K 1130
2020
Q4
$383K Buy
+1,745
New +$383K 0.05% 467